TOLMAR, INC.
FORT COLLINS, CO

TOLMAR, INC., FORT COLLINS

At Tolmar, science drives everything we do. Through a relentless focus on technology, science, partnership and excellence, we seek to advance patient care and deliver value through innovative therapies and services. The Tolmar portfolio includes specialty products for urology, oncology and dermatology. The invention, development and worldwide approval of ELIGARD® (leuprolide acetate for injectable suspension) delivers innovation and commitment to the urology, oncology and hospital communities, providers and patients. Technology-driven development and high-quality manufacturing capabilities established Tolmar as a leading player for topical generics in the field of dermatology. Our fully integrated model ensures that Tolmar controls all aspects of the research, development, approval and commercialization of our products. With numerous FDA-approved products, we have earned a global reputation for our strict standards, expertise in manufacturing and proven record in regulatory and clinical development. Our robust pipeline harnesses our expertise and experience, and ensures that we will carry this legacy well into the future. Tolmar is privately held, with an established Commercial presence across the U.S. Our state-of-the-art product development and manufacturing facilities and headquarters are based in Northern Colorado. Tolmar is always looking for qualified candidates to join our dedicated team. View our current employment opportunities. Our Company As a privately held company, Tolmar takes pride in our ability to be both flexible and responsive. We strive to provide a level of service to all our stakeholders that is unmatched. Tolmar is comprised of a high-performing team of more than 700, who are united by our passion, mission and vision. Our size enables us to deliver on our commitments with steadfast reliability while maintaining a creative and nimble approach. Our company, and our values, are directed by strong leadership with decades of combined industry expertise. Tolmar’s established commercial presence spans broad distribution channels, and urology, oncology and hospital settings across the United States. Tolmar’s team of highly-trained research scientists, chemists and engineers work to deliver treatments that advance patient care around the world. With our state-of the-art manufacturing facilities headquartered in Northern Colorado, along with our proven research and development, clinical development, regulatory and production capabilities, Tolmar is an established, sought-after partner. Tolmar continues to grow our capabilities within our established specialty pharmaceutical markets by investing in the latest technologies and production methods. We show our dedication to patients, healthcare providers, and the community at large through our product offerings, programs and unsurpassed engagement to serve the needs of our stakeholders. Tolmar’s culture is driven by our values. A legacy of leading-edge product development and partnerships Tolmar is proud to have earned a reputation for performance and innovation. Through a progressive company culture, Tolmar has established a legacy as a trusted name in the research, development and manufacturing of high quality topical products used in dermatology, and extended release dosing forms for products commonly used in urology and oncology. Founded in 2006, we have built a company known internationally for our advanced drug delivery capabilities and our unmatched commitment to our partners, and to the patients and provider communities we serve. Since our inception, Tolmar has produced 21 marketed products supported by 5 New Drug Applications (NDAs) and 16 Abbreviated New Drug Applications (ANDAs) across urology and oncology and dermatology. With more products forthcoming, our dedicated pipeline reflects Tolmar’s future-focused approach. Tolmar’s pipeline reflects our history of dedication and our continued efforts to innovate. Our unique drug delivery platforms and development expertise fuels discovery of new therapies to meet important needs and advance patient care. Our Products, Our Legacy Tolmar’s reputation is founded on the quality and consistency of our products. As a fully-integrated pharmaceutical company we maintain strict manufacturing standards through every phase of the process. Our diverse portfolio of specialty treatments is manufactured according to these standards. Tolmar, at its sole discretion, may reject an application for various reasons. Tolmar will not provide funding to promote any Tolmar product for advertising, displays, booths, or promotional exhibit fees (please contact Tolmar commercial division or your local representative for such requests) for educational grant requests from organizations that have not returned unused funds or provided reconciliation information to Tolmar for programs sponsored by individual healthcare providers or an individual’s medical practice for nonmedical education purposes (eg, research studies, including clinical studies and investigator-initiated studies (IISs); charitable contributions; promotional or commercial marketing programs or advertisements; corporate sponsorship agreements; private schools/colleges/universities attended by physicians or their family members; religious programs or medical missions to foreign countries) to debarred institutions or groups, or to CME providers on probation by ACCME (or similar accrediting body) Please submit the following documents to Tolmar within 60 days of the CME/IME course completion: Tolmar’s dedicated, patient-focused company culture sets high standards for corporate responsibility and commercial compliance. Our vision, values and mission to improve the lives of patients around the world guide Tolmar’s commitment to compliance in all areas of our business. Tolmar makes a proactive effort to ensure our employees and contractors adhere to our standard of conduct. Tolmar Pharmaceuticals Inc., has established a Commercial Compliance Program designed to meet the requirements of all applicable laws. We place a significant importance on integrity, and to that end we strive to foster a culture that represents our dedication to ethics. The Tolmar Pharmaceuticals Inc., Commercial Compliance Program aids in preventing and detecting violations of such laws and our company policies.

KEY FACTS ABOUT TOLMAR, INC.

Company name
TOLMAR, INC.
Status
Active
Filed Number
F09000000276
FEI Number
205990340
Date of Incorporation
January 20, 2009
Age - 16 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://tolmar.com
Phones
(970) 212-4500
(877) 986-5627
(224) 880-5770
(877) 712-4575

TOLMAR, INC. NEAR ME

Principal Address
701 CENTRE AVE,
FORT COLLINS,
CO,
80526

See Also

Officers and Directors

The TOLMAR, INC. managed by the three persons from BUFFALO GROVE, FORT COLLINS on following positions: CEO,, Dire, Vice President

Anil D'Souza

Position
CEO, Active
From
BUFFALO GROVE, IL, 60089

Jeff Lederman

Position
Dire Active
From
FORT COLLINS, CO, 80526

Robyn Vilkaitis

Position
Vice President Active
From
FORT COLLINS, CO, 80526





Registered Agent is CORPORATION SERVICE COMPANY

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301, 2525

Annual Reports

2024
January 3, 2024
2023
January 18, 2023